Abstract:Candida glabrata (Nakaseomyces glabratus) is an opportunistic fungal pathogen that has become a significant concern in clinical settings due to its increasing resistance to antifungal treatments. Understanding the genetic basis of its pathogenicity and resistance mechanisms is crucial for developing new therapeutic strategies. One powerful method of studying gene function is through targeted gene deletion. This paper outlines a comprehensive protocol for the deletion of genes in C. glabrata, encompassing primer design, preparation of electrocompetent cells, transformation, and finally confirmation of the gene deletion. The protocol begins with the identification and design of primers necessary for generating deletion constructs, involving the precise targeting of up- and downstream regions flanking the gene of interest to ensure high specificity and efficiency of homologous recombination. Followed is the preparation of electrocompetent cells, a critical step for successful transformation. Transformation of the competent cells is achieved through electroporation, facilitating the introduction of exogenous DNA into the cells. This is followed by the selection and confirmation of successfully transformed colonies. Confirmation involves the use of colony PCR to verify the correct integration of the NAT resistance cassette and deletion of the target gene. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Primer design for gene deletion in C. glabrata Basic Protocol 2: Preparing competent C. glabrata cells Basic Protocol 3: Transforming C. glabrata using electroporation Basic Protocol 4: Confirming deletion strains with colony PCR.

The topoisomerase I gene from Candida albicans.

TOP2 Gene Disruption Reduces Drug Susceptibility by Increasing Intracellular Ergosterol Biosynthesis in Candida Albicans

Topoisomerase 1 Regulates Gene Expression in Neurons Through Cleavage Complex-Dependent and -Independent Mechanisms.

A Yeast-Based Screening System for Differential Identification of Poisons and Suppressors of Human Topoisomerase I

Pat1: a Topoisomerase II-associated Protein Required for Faithful Chromosome Transmission in Saccharomyces Cerevisiae.

Human mitochondrial topoisomerase I

Active site mutations in DNA topoisomerase I distinguish the cytotoxic activities of camptothecin and the indolocarbazole, rebeccamycin

Cloning and characterization of the 5'-flanking region of the human topoisomerase II alpha gene.

Targeted repression of topA by CRISPRi reveals a critical function for balanced DNA topoisomerase I activity in the Chlamydia trachomatis developmental cycle

Cloning and Identification of Genes Related with Morphogenesis of Candida albicans.

Global regulatory roles of the cAMP/PKA pathway revealed by phenotypic, transcriptomic and phosphoproteomic analyses in a null mutant of the PKA catalytic subunit in Candida albicans: Global roles of the cAMP/PKA pathway in C. albicans

Isogenic strain construction and gene mapping in Candida albicans.

Deletion of the fungus specific protein phosphatase Z1 exaggerates the oxidative stress response in Candida albicans

The Actin-Related Protein Sac1 is Required for Morphogenesis and Cell Wall Integrity in Candida Albicans

Topoisomerase III is Essential for Accurate Nuclear Division in Schizosaccharomyces Pombe.

The General Transcriptional Repressor Tup1 Governs Filamentous Development in Candida Tropicalis.

Global regulatory roles of the cAMP/PKA pathway revealed by phenotypic, transcriptomic and phosphoproteomic analyses in a null mutant of the PKA catalytic subunit in Candida albicans

Deletion of Topoisomerase 1 in excitatory neurons causes genomic instability and early onset neurodegeneration

Cloning and characterization of the low-affinity cyclic AMP phosphodiesterase gene of Saccharomyces cerevisiae

Isolation of Cdna Clones Encoding the Β Isozyme of Human DNA Topoisomerase II and Localisation of the Gene to Chromosome 3P24

Genetic Manipulation of Candida glabrata